(Q34301730)

English

Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

apoptotic process

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Miyake H

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hara I

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kamidono S

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gleave ME

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

337-349

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Management of hormone refractory prostate cancer: current standards and future prospects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Clusterin: physiologic and pathophysiologic considerations.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Insulin-like growth factors and their binding proteins: biological actions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2001.00311.X

21 January 2018

Identifiers

10.1046/J.1442-2042.2001.00311.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34301730&oldid=2039671417"